Physician profile
David Mckeown
NPI 1376988014
$10,045.10
in general payments reported to CMS, 2019-2025
9 companies · $2,089 in 2025
The $2,089 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,167 · 2021: $55.89 · 2022: $1,041 · 2023: $69.66 · 2024: $1,622 · 2025: $2,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,112 · Travel and Lodging: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,112.15 |
| Travel and Lodging | $168.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,442.06 | 2020-2025 | |
| Conmed Corporation | $174.51 | 2024 | Airseal |
| Medtronic, INC. | $125.55 | 2021-2023 | Signia |
| Ethicon US, LLC | $108.81 | 2022-2025 | Enseal, Stratafix |
| Braintree Laboratories, INC. | $59.13 | 2025 | Suflave |
| Smith+Nephew, INC. | $44.94 | 2024 | Grafix Pl, Stravix Pl, Oasis |
| Takeda Pharmaceuticals U.S.A., INC. | $41.05 | 2024-2025 | Gattex |
| Pacira Pharmaceuticals Incorporated | $27.54 | 2024 | Exparel |
| Tactile Systems Technology INC | $21.51 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mckeown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.